President and CEO of Avanir Pharmaceuticals (AVNR, Financial) Keith Katkin sells 35,025 shares of AVNR on 01/05/2010 at an average price of $1.92 a share.
Avanir Pharmaceuticals has a market cap of $160.5 million; its shares were traded at around $1.93 with and P/S ratio of 38.2.
Avanir Pharmaceuticals has a market cap of $160.5 million; its shares were traded at around $1.93 with and P/S ratio of 38.2.
CEO Recent Trades:
- Sell:: President and CEO Keith Katkin sold 35,025 shares of AVNR stock on 01/05/2010 at the average price of 1.92, the price of the stock has increased by 0.52% since.
- Sell:: President and CEO Keith Katkin sold 37,335 shares of AVNR stock on 12/15/2009 at the average price of 1.82, the price of the stock has increased by 6.04% since.
Directors and Officers Recent Trades:
- Sell:: 10% Owner Jay Moorin sold 1,778,992 shares of AVNR stock on 10/13/2009 at the average price of 2.31, the price of the stock has decreased by 16.45% since.
- Sell:: Sr. VP, Chief Medical Officer Randall Kaye sold 2,000 shares of AVNR stock on 09/15/2009 at the average price of 2.1, the price of the stock has decreased by 8.1% since.
- Sell:: 10% Owner Ventures Fund Vi, L.p. Vivo sold 411,366 shares of AVNR stock on 07/31/2009 at the average price of 2.33, the price of the stock has decreased by 17.17% since.
